https://www.selleckchem.com/pr....oducts/ertugliflozin
01) and recurrence free survival following liver transplant (89% versus 65%, p=0.04). Among those with asymptomatic CCA, MRI detection (compared to ultrasound) was associated with reduction in both mortality (hazard ratio [HR], 0.10; 95% CI, 0.01-0.96) and CCA progression after transplant listing (HR 0.10; 95%CI, 0.01-0.9. These benefits continued among patients who had annual monitoring and PSC for more than 1 year before CCA was diagnosed. MRI is superior to ultrasound for the detection of early stage CCA in patients with PSC.
Like
Comment
Share
